| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $132.38B | $143.15B | $147.40B |
| YoY Revenue Growth % | -7.5% | -2.9% | — |
| Gross Profit | $16.28B | $13.19B | — |
| Gross Margin % | 12.3% | 9.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $5.20B | $2.50B | $8.28B |
| Operating Margin % | 3.9% | 1.7% | 5.6% |
| Net Income (GAAP) | $4.40B | $2.12B | $7.01B |
| EBITDA (Normalized) | $9.96B | $7.65B | $13.58B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.96B | $4.19B | $7.03B |
| Capital Expenditures (CapEx) | $5.96B | $6.44B | $6.63B |
| Free Cash Flow (FCF) | -$994.9M | -$2.25B | $396.0M |
| FCF Margin % | -0.8% | -1.6% | 0.3% |
| Return on Invested Capital (ROIC %) | 8.6% | 4.3% | 6.1% |
| Cash & Short-Term Equivalents | $1.12B | $1.74B | — |
| Total Debt (Short + Long Term) | $19.55B | $19.85B | $41.39B |
| Total Stockholders' Equity | $29.09B | $27.41B | $84.90B |